| 000 | 01616 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516200948.0 | ||
| 264 | 0 | _c20150224 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1543-8392 | ||
| 024 | 7 |
_a10.1021/mp4005904 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Yingzhe | |
| 245 | 0 | 0 |
_aEnhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. _h[electronic resource] |
| 260 |
_bMolecular pharmaceutics _cApr 2014 |
||
| 300 |
_a1140-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCytidine Deaminase _xmetabolism |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicelles |
| 650 | 0 | 4 |
_aPhosphatidylethanolamines _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aVitamin E _xadministration & dosage |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aFan, Wei | |
| 700 | 1 | _aDai, Xin | |
| 700 | 1 | _aKatragadda, Usha | |
| 700 | 1 | _aMckinley, DeAngelo | |
| 700 | 1 | _aTeng, Quincy | |
| 700 | 1 | _aTan, Chalet | |
| 773 | 0 |
_tMolecular pharmaceutics _gvol. 11 _gno. 4 _gp. 1140-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/mp4005904 _zAvailable from publisher's website |
| 999 |
_c23595277 _d23595277 |
||